In a filing, Kura Oncology Inc revealed its Officer WILSON TROY EDWARD acquired Company’s shares for reported $0.33 million on Sep 29 ’25. In the deal valued at $9.05 per share,36,615 shares were bought.
Then, LEONI MOLLIE bought 12,314 shares, generating $111,442 in total proceeds.
Before that, POWL BRIAN T bought 8,891 shares. Kura Oncology Inc shares valued at $80,464 were divested by the Officer at a price of $9.05 per share.
Guggenheim initiated its Kura Oncology Inc [KURA] rating to a Neutral in a research note published recently. A number of analysts have revised their coverage, including BTIG Research’s analysts, who decreased its forecast for the stock in early February from “a Buy” to “a Neutral”. UBS began covering KURA with “Buy” recommendation on October 24, 2024. Stifel revised its rating on October 14, 2024. It rated KURA as “a Hold” which previously was an “a Buy”.
Price Performance Review of KURA
On Friday, Kura Oncology Inc [NASDAQ:KURA] saw its stock jump 4.70% to $9.57. Over the last five days, the stock has gained 5.75%. Kura Oncology Inc shares have fallen nearly -50.18% since the year began. Nevertheless, the stocks have risen 9.87% over the past one year. While a 52-week high of $19.73 was reached on 10/03/25, a 52-week low of $5.41 was recorded on 04/07/25.
Levels Of Support And Resistance For KURA Stock
The 24-hour chart illustrates a support level at 9.27, which if violated will result in even more drops to 8.97. On the upside, there is a resistance level at 9.81. A further resistance level may holdings at 10.05.
How much short interest is there in Kura Oncology Inc?
A steep rise in short interest was recorded in Kura Oncology Inc stocks on 2025-09-15, growing by 2.85 million shares to a total of 10.85 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 8.0 million shares. There was a rise of 26.3%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 22, 2023 when Mizuho began covering the stock and recommended ‘”a Buy”‘ rating along with a $26 price target.
